484 related articles for article (PubMed ID: 24766381)
1. Osteoporosis prevention, screening, and treatment: a review.
Kling JM; Clarke BL; Sandhu NP
J Womens Health (Larchmt); 2014 Jul; 23(7):563-72. PubMed ID: 24766381
[TBL] [Abstract][Full Text] [Related]
2. Cost effectiveness of fracture prevention in postmenopausal women who receive aromatase inhibitors for early breast cancer.
Ito K; Blinder VS; Elkin EB
J Clin Oncol; 2012 May; 30(13):1468-75. PubMed ID: 22370313
[TBL] [Abstract][Full Text] [Related]
3. Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.
Lim LS; Hoeksema LJ; Sherin K;
Am J Prev Med; 2009 Apr; 36(4):366-75. PubMed ID: 19285200
[TBL] [Abstract][Full Text] [Related]
4. The cost effectiveness of bisphosphonates for the prevention and treatment of osteoporosis: a structured review of the literature.
Fleurence RL; Iglesias CP; Johnson JM
Pharmacoeconomics; 2007; 25(11):913-33. PubMed ID: 17960951
[TBL] [Abstract][Full Text] [Related]
5. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
[TBL] [Abstract][Full Text] [Related]
6. FRAX or fiction: determining optimal screening strategies for treatment of osteoporosis in residents in long-term care facilities.
Greenspan SL; Perera S; Nace D; Zukowski KS; Ferchak MA; Lee CJ; Nayak S; Resnick NM
J Am Geriatr Soc; 2012 Apr; 60(4):684-90. PubMed ID: 22316237
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of bone mineral density testing and osteoporosis management following low- and high-energy fractures.
Angthong C; Rodjanawijitkul S; Samart S; Angthong W
Acta Orthop Traumatol Turc; 2013; 47(5):318-22. PubMed ID: 24164940
[TBL] [Abstract][Full Text] [Related]
8. Interest of a prescreening questionnaire to reduce the cost of bone densitometry.
Ben Sedrine W; Broers P; Devogelaer JP; Depresseux G; Kaufman JM; Goemaere S; Reginster JY
Osteoporos Int; 2002 May; 13(5):434-42. PubMed ID: 12086356
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice guidelines for the diagnosis and management of osteoporosis. Scientific Advisory Board, Osteoporosis Society of Canada.
CMAJ; 1996 Oct; 155(8):1113-33. PubMed ID: 8873639
[TBL] [Abstract][Full Text] [Related]
10. Cost effectiveness of ibandronate for the prevention of fractures in inflammatory bowel disease-related osteoporosis: cost-utility analysis using a Markov model.
Kreck S; Klaus J; Leidl R; von Tirpitz C; Konnopka A; Matschinger H; König HH
Pharmacoeconomics; 2008; 26(4):311-28. PubMed ID: 18370566
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Osteoporosis Screening Strategies for Men.
Nayak S; Greenspan SL
J Bone Miner Res; 2016 Jun; 31(6):1189-99. PubMed ID: 26751984
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness of osteoporosis screening strategies for hip fracture prevention in older Chinese people: a decision tree modeling study in the Mr. OS and Ms. OS cohort in Hong Kong.
Su Y; Lai FTT; Yip BHK; Leung JCS; Kwok TCY
Osteoporos Int; 2018 Aug; 29(8):1793-1805. PubMed ID: 29774400
[TBL] [Abstract][Full Text] [Related]
13. Is treatment of early postmenopausal women with bisphosphonates justified?
Epstein S
Int J Clin Pract; 2007 Jun; 61(6):963-71. PubMed ID: 17504359
[TBL] [Abstract][Full Text] [Related]
14. Summary of AHRQ's comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report.
Levis S; Theodore G
J Manag Care Pharm; 2012 May; 18(4 Suppl B):S1-15; discussion S13. PubMed ID: 22716221
[TBL] [Abstract][Full Text] [Related]
15. Update on Osteoporosis.
Yedavally-Yellayi S; Ho AM; Patalinghug EM
Prim Care; 2019 Mar; 46(1):175-190. PubMed ID: 30704657
[TBL] [Abstract][Full Text] [Related]
16. [Image assessment of the treatment effect on osteoporosis: bisphosphonates].
Sone T
Clin Calcium; 2011 Jul; 21(7):1041-6. PubMed ID: 21719985
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and treatment of osteoporosis.
Sweet MG; Sweet JM; Jeremiah MP; Galazka SS
Am Fam Physician; 2009 Feb; 79(3):193-200. PubMed ID: 19202966
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of proposals of Belgian Social Security Institute for reimbursement of bone densitometry tests. Toward a cost-effective strategy for osteoporosis screening?
Ben Sedrine W; Ethgen O; Devogelaer JP; Depresseux G; Kaufman JM; Goemaere S; Reginster JY
Aging Clin Exp Res; 2004 Oct; 16(5):413-9. PubMed ID: 15636469
[TBL] [Abstract][Full Text] [Related]
19. Clinical use of bone densitometry: scientific review.
Cummings SR; Bates D; Black DM
JAMA; 2002 Oct; 288(15):1889-97. PubMed ID: 12377088
[TBL] [Abstract][Full Text] [Related]
20. Screening for osteoporosis: an update for the U.S. Preventive Services Task Force.
Nelson HD; Haney EM; Dana T; Bougatsos C; Chou R
Ann Intern Med; 2010 Jul; 153(2):99-111. PubMed ID: 20621892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
